Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GLPG-3667 by Galapagos for Systemic Lupus Erythematosus: Likelihood of Approval
GLPG-3667 is under clinical development by Galapagos and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase...
GLPG-3667 by Galapagos for Ulcerative Colitis: Likelihood of Approval
GLPG-3667 is under clinical development by Galapagos and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I...
GLPG-3667 by Galapagos for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
GLPG-3667 is under clinical development by Galapagos and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to GlobalData,...